Sign inJoin waitlistJoin the waitlist

Piro Lito

Enid A. Haupt Chair in Therapeutic Research · New York Presbyterian Hospital

Credentials: · · · · ·

History

New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
2011–2013
Internal Medicine
Beth Israel Deaconess Medical Center
2008–2011
Michigan State Univ Coll Osteo Med
2004–2008

Research

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
New England Journal of Medicine · 2020 · 1,421 citations
The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Case report · Cancer Discovery · 2020 · 1,061 citations
Acquired Resistance to KRASG12C Inhibition in Cancer
New England Journal of Medicine · 2021 · 1,038 citations

GR
Gregory Riely
13 papers
JX
Jenny Xue
12 papers
KA
Kathryn Arbour
12 papers
BL
Bob Li
11 papers
Charles Rudin
9 papers
MK
Mark Kris
8 papers
NR
Neal Rosen
8 papers
HY
Helena Yu
6 papers
ML
Marc Ladanyi
6 papers
MH
Matthew Hellmann
6 papers
Yonina Murciano-Goroff
5 papers · 5 as a fellow
AI
Afsheen Iqbal
4 papers

Grants

Targets for Therapy for Carcinomas of the Lung
National Cancer Institute · P01
Contact PI · $2.4M · Sloan-Kettering Inst Can Research
2007–2031
Dissecting KRAS Oncoprotein Signaling with Small Molecule Inhibitors
National Cancer Institute · R01
Contact PI · $3.8M · Sloan-Kettering Inst Can Research
2018–2028
Mechanisms of Adaptation and Resistance to Emerging Therapies for Lung Cancer
National Cancer Institute · R01
Contact PI · $2M · Sloan-Kettering Inst Can Research
2023–2028
Studies on the Effects of a Novel Intermittent Therapy on Intratumoral Clonal Architecture and Resistance
National Cancer Institute · R01
Contact PI · $2M · Sloan-Kettering Inst Can Research
2019–2025